Adaptimmune Therapeutics PLC (ADAPY) stock
ADAPYOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.04+0.00 (+9.38%)
Close on Oct 19, 2026Market cap $55.46MP/E –Yield –
Adaptimmune Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Adaptimmune Therapeutics's market cap was $55.66M on Oct 19, 2026, against $79.83M a year earlier. Over the last 5 years it ranged from $9.70M to $3.89B, with a median of $1.05B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $55.66M | +34.6% |
| 2025 | Dec 31, 2025 | $41.35M | -95.0% |
| 2024 | Dec 31, 2024 | $826.94M | -23.4% |
| 2023 | Dec 29, 2023 | $1.08B | -24.7% |
| 2022 | Dec 30, 2022 | $1.43B | -59.2% |
| 2021 | Dec 31, 2021 | $3.51B | -29.8% |
| 2020 | Dec 31, 2020 | $5.00B | +561.0% |
| 2019 | Dec 31, 2019 | $757.14M | -79.0% |
| 2018 | Dec 31, 2018 | $3.61B | -4.0% |
| 2017 | Dec 29, 2017 | $3.75B | +118.3% |
| 2016 | Dec 30, 2016 | $1.72B | -66.4% |
| 2015 | Dec 31, 2015 | $5.12B | – |
See a number that looks wrong?